Thursday, March 5, 2015

An Emerging Face of Cancer: Today’s Understanding



An Emerging Face of Cancer: Today’s Understanding

Case Study
Sally sat motionless with her hands gripping the steering wheel after she turned off the car in her driveway. Thirty minutes before she was meeting with her doctor to review some tests, when she heard the words that would change her life forever. The words, “You have ovarian cancer” repeated through her mind ever since the doctor spoke them. She didn’t remember much after that except looking an x-ray that showed the cancer had spread from her ovaries to several locations throughout her “abdominal area”.
Sally did not know what to do next. She had been divorced for 6 months and did not feel comfortable calling her ex-husband. Sally’s friend had offered to go to the doctor’s visit with her, but Sally never wanted to inconvenience her friends. Most had their hands full with children and elderly parents. She thought having cancer meant you received chemotherapy and likely may not survive anyway. Sally did not know what cancer was, how to live with it or what do next.

Introduction
Many years before the body is effected in anyway, a potentially catastrophic change happens. It is likely an accumulation of one or many environmental factors that trigger one gene, likely an oncogene, in one cell projecting a new aberrant genomic pattern that has the potential to destroy the human body. This is cancer.
Cells of each organ or tissue divide to grow in a controlled manner specific to that organ. This way when old or poorly functioning cells die new cells replace them. Thus providing a relatively constant mass of specialized cells needed to maintain proper function in each organ or tissue. When the genetic material of a cell (DNA) is damaged or is triggered “on”, this is considered a mutation and affects the growth and cell division rate of that cell and subsequent expanding cell line of its progeny.

Text Box: The excessive growth rate causes a mass of cancer cells, called a tumorMost commonly when a cell is damaged or has genetic malfunction, the affected cell will simply die. Cancer occurs when cells undergo a series of genetic alterations that involve a gene responsible for regulating the rate of cell growth and division to form new cells. As a result,  these new aberrant cancer cells survive longer and still new cells are made when the body does not need them or have space for them. This accumulation of extra non-functioning cells form a mass of tissue called a tumor.mage titled Loss of Normal Growth Control. The image shows normal cell division and normal cell suicide or apoptosis of a damaged cell. It also shows cancer cell division, through several mutation stages, ending in uncontrolled growth.

Cancer is a very broad term that encompasses diseases that manifest clinically as a result abnormally dividing cells that lost the ability to control their rate of growth. As a result, the cluster of cells grows to cause dysfunction in the initial organ and then continue to grow to invade other organs. The cancer cells “grow wild”, spread to adjacent tissue and some types spread throughout the body as transported by the blood stream and lymphatic system.  For example, ovarian cancer starts in the ovaries and usually spreads by into the surrounding abdominal cavity and colon by the type clinical symptoms warrant a doctors visit.

Cancer types
There are over 100 types of cancer and the organ that they started names most by the name of the apparent type of cell involved. A carcinoma is a cancer of the skin or outside ling of an internal organ.
Squamous cell carcinoma occurs most commonly along the breathing tract, mouth to lung. Squamous cells cover the majority of the respiratory tract and after years of carcinogenic irritants (smoke, chewing tobacco) a gene in one or a group of squamous cells initiates a cancer genomic process. Sarcoma is cancer of the bone, cartilage, fat, muscle, blood vessels or connective tissues.  Cancer that originates in the bone marrow, that is responsible for forming blood products (platelets, red and white blood cells), is called Leukemia. The rapid production of abnormal blood cells in leukemia take precedence over production of the critical production of healthy blood cells the body desperately depends on. Lymphoma and myeloma are cancers of the immune system. The cancers of the brain and spinal cord are unique because the cell types primarily exist in the brain. For example, an astrocytoma originates for the abnormal reproduction of astrocytes, which are only present in the brain.

Behavior of a tumor
A tumor or cancer cells are usually not detected until they cause enough interference to prevent one or more organs to function appropriately. For example, the ovary has space to grow significantly before it interferes with function of other abdominal organs. However, the local invasion of cells into the abdominal cavity results in fluid secretion and accumulation where the weight of fluid is not normally present, creating discomfort. In addition, the “aggressive” cell type of some ovarian cancers rapidity invades the colon and produce gastrointestinal symptoms of bleeding, obstruction or diarrhea. T cell leukemia uses most bone marrow supplies to produce abnormal T cell’s (one type of white blood cell) that there is enough to produce red blood cells or platelets.

Prevalence of Cancer
Cancer continues to be a major health problem throughout the world. In In the U.S., cancer accounts for approximately 25% of all deaths that occur each year. Between 2006-2010 over 1.5 million Americans were diagnosed with cancer. With over one-third of those dying form a  cancer related cause.  (http://onlinelibrary.wiley.com.ezproxy.med.nyu.edu/doi/10.3322/caac.21208/pdf)
Although grim, these statistics reflect small improvements. Over the past 5 years cancer related death rates have decreased by about 1.5%. The incidence or cancer has decreased 0.6% in men and has remained unchanged in woman. The death rate from cancer peaked in 1991 and has been slowing since that time. The largest decline (55%) occurred in black men aged 40-49 years.

Text Box: Most Common Cancer Types
Men
Prostate  27%
Lung         14%
Bladder     7%
Melanoma of skin 5%
Women
Breast     29%
Lung         13%
Uterine    6%
Thyroid   6%
https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcS3zPTmdMDARG4mTJZbjqR9actfg4polnNI2sx6-35pBht7qi2c

Autoimmune Movement Disorders



Autoimmune Movement Disorders

Ross Finesmith MD


Sydenham’s Chorea is the most understood autoimmune basal ganglia autoimmune condition associated with a post-infectious state.1,2 This condition manifests with choreaform movements and neuropsychiatric symptoms. There is immunological laboratory confirmation and clinical therapeutic research studies that support the autoimmune reaction in Sydenham’s Chorea is caused by group A-Streptococcus (GAS) infections.3 4 5 6 There is a spectrum of immune mediated basal ganglia disease processes that manifest as neuropsychiatric conditions.5 Evidence support that Sydenham’s Chorea and Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus (PANDAS) are caused by a mechanism of autoantibody mimicry.1,7

In an effort to clear the body from infection, an individual’s immune system produces antibodies that specifically lock onto GAS surface antigens to neutralize the invader; however in some persons the surface antigens of specific brain cells has a similar cell antigen as the GAS bacterium. These neuronal surface antigens are stimulated by the GAS directed antibody and results in neuronal cell dysfunction which generates abnormal movements. These GAS directed antibodies are reported to cause the clinical symptoms seen in Sydenham’s Chorea and PANDAS.

The abnormal autoimmune response in Sydenham’s Chorea and PANDAS target and damage specific cortical, striatal, thalamic and basal ganglia cells by locking into their surface antigens. The autoimmune attack on these brain cells results in abnormal function, and subsequently, neuropsychiatric symptoms. Identifying and testing for the presence of these antibodies allows for an effective diagnostic panel of tests and may provide insight to more specific therapeutic interventions.

Dopamine (DA) is a prominent neurotransmitter and plays a key role in motor movements orchestrated through both cortical and sub-cortical brain regions. Parkinson’s disease is the most common neurological disorder to be caused by abnormal DA activity. Sydenham’s Chorea, Tourette’s syndrome, tics, autoimmune encephalitis and other neuropsychiatric disease states have been discovered to relate to abnormal DA activity as well.8,9

There are 5 subtypes of dopamine receptors (D1-D5) and each has unique composite, structure and function.10 The basal ganglia and cortex have a high concentration of receptor types D1 and D2. An animal model of tic behaviors was shown to have significantly increased dopamine D1 receptor activity in the cortical and limbic neurocircuitry.11 In addition, abnormal D2 receptor activity in the basal ganglia has been reported in movement disorders.12 This correlates with the effectiveness of pharmalogical D1and D2 receptor blocking agents, such as the neuroleptics that effectively suppress chorea and tics.13 D2 receptor antibodies have been found in the serum of patients with autoimmune induced movement and psychiatric disorders and there were no D2 antibodies detected in healthy controls.14 Recent studies have demonstrated that autoantibodies in Sydenham’s’ Chorea and PANDAS specifically cross-react with brain D1 and D2 receptors.15

It is our current understanding in Sydenham’s Chorea that antineuronal antibodies are generated and cross the blood-brain barrier to induce neuronal dopamine release by activating calcium protein kinase II (CaMKII). This release of excessive DA in the basal ganglia is believed to create the abnormal movements.16 In addition, studies have reported isolating autoantibodies that bind to neuronal cell gangliosides and intracellular tubulin that play a role in generating abnormal movement patterns as well.17

It is important to include GAS related autoimmune movement disorders in the differential for motor tics and new onset chorea. A careful history may reveal previous signs and symptoms of GAS infections, such as sore throat and cold-like symptoms. A panel to identify antibody’s associated with PANDA’s and Sydenham’s Chorea includes: anti-dopamine D1, anti-dopamine D2, anti-lysoganglioside, anti-tubulin and cam kinase II neuronal cell stimulation assay. These measurements will support a auto-immune diagnosis and antibiotics will reduce the bacteria load.  With this treatment, antibody levels will gradually be reduced followed by a reduction in the clinical movement disorder.





1.         Kirvan CA, Swedo SE, Kurahara D, Cunningham MW. Streptococcal mimicry and antibody-mediated cell signaling in the pathogenesis of Sydenham's chorea. Autoimmunity. Feb 2006;39(1):21-29.
2.         Nausieda PA, Grossman BJ, Koller WC, Weiner WJ, Klawans HL. Sydenham chorea: an update. Neurology. Mar 1980;30(3):331-334.
3.         Dale RC, Candler PM, Church AJ, Wait R, Pocock JM, Giovannoni G. Neuronal surface glycolytic enzymes are autoantigen targets in post-streptococcal autoimmune CNS disease. Journal of neuroimmunology. Mar 2006;172(1-2):187-197.
4.         Perlmutter SJ, Leitman SF, Garvey MA, et al. Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood. Lancet. Oct 2 1999;354(9185):1153-1158.
5.         Hachiya Y, Miyata R, Tanuma N, et al. Autoimmune neurological disorders associated with group-A beta-hemolytic streptococcal infection. Brain & development. Nov 8 2012.
6.         Walker K, Brink A, Lawrenson J, Mathiassen W, Wilmshurst JM. Treatment of sydenham chorea with intravenous immunoglobulin. Journal of child neurology. Feb 2012;27(2):147-155.
7.         Kirvan CA, Swedo SE, Heuser JS, Cunningham MW. Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea. Nature medicine. Jul 2003;9(7):914-920.
8.         Steeves TD, Ko JH, Kideckel DM, et al. Extrastriatal dopaminergic dysfunction in tourette syndrome. Annals of neurology. Feb 2010;67(2):170-181.
9.         Jijun L, Zaiwang L, Anyuan L, et al. Abnormal expression of dopamine and serotonin transporters associated with the pathophysiologic mechanism of Tourette syndrome. Neurology India. Jul-Aug 2010;58(4):523-529.
10.       Beaulieu JM, Gainetdinov RR. The physiology, signaling, and pharmacology of dopamine receptors. Pharmacological reviews. Mar 2011;63(1):182-217.
11.       Nordstrom EJ, Burton FH. A transgenic model of comorbid Tourette's syndrome and obsessive-compulsive disorder circuitry. Molecular psychiatry. 2002;7(6):617-625, 524.
12.       Nikolaus S, Antke C, Muller HW. In vivo imaging of synaptic function in the central nervous system: I. Movement disorders and dementia. Behavioural brain research. Dec 1 2009;204(1):1-31.
13.       Bruggeman R, van der Linden C, Buitelaar JK, Gericke GS, Hawkridge SM, Temlett JA. Risperidone versus pimozide in Tourette's disorder: a comparative double-blind parallel-group study. The Journal of clinical psychiatry. Jan 2001;62(1):50-56.
14.       Dale RC, Merheb V, Pillai S, et al. Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders. Brain : a journal of neurology. Nov 2012;135(Pt 11):3453-3468.
15.       Brimberg L, Benhar I, Mascaro-Blanco A, et al. Behavioral, pharmacological, and immunological abnormalities after streptococcal exposure: a novel rat model of Sydenham chorea and related neuropsychiatric disorders. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. Aug 2012;37(9):2076-2087.
16.       Kirvan CA, Swedo SE, Snider LA, Cunningham MW. Antibody-mediated neuronal cell signaling in behavior and movement disorders. Journal of neuroimmunology. Oct 2006;179(1-2):173-179.
17.       Kirvan CA, Cox CJ, Swedo SE, Cunningham MW. Tubulin is a neuronal target of autoantibodies in Sydenham's chorea. J Immunol. Jun 1 2007;178(11):7412-7421.

Tuesday, March 3, 2015

Science by Ross Finesmith: Is Current Day Use of Fructose Dangerous?

Science by Ross Finesmith: Is Current Day Use of Fructose Dangerous?: Is Current Day Use of Fructose Dangerous? Ross Finesmith MD Fructose is a highly pleasurable fruit sugar found in many plant pr...

Science by Ross Finesmith: Nutritional supplements and sleep

Science by Ross Finesmith: Nutritional supplements and sleep: Nutritional supplements and sleep Ross FinesmithMD INTRODUCTION It has been estimated that over 18% of the population use nat...

Science by Ross Finesmith: Science by Ross Finesmith: What Is Telemedicine?

Science by Ross Finesmith: Science by Ross Finesmith: What Is Telemedicine?: Science by Ross Finesmith: What Is Telemedicine? : Where does telemedicine in stroke care fit in our healthcare system? Ross Finesmith MD ...

Science by Ross Finesmith: Home

Science by Ross Finesmith: Home: Home

Science by Ross Finesmith: Science by Ross Finesmith: Science by Ross Finesmi...

Science by Ross Finesmith: Science by Ross Finesmith: Science by Ross Finesmi...: Science by Ross Finesmith: Science by Ross Finesmith: Science by Ross Finesmi... : Science by Ross Finesmith: Science by Ross Finesmith: Is ...